RECODE THERAPEUTICS
ReCode Therapeutics is a development-stage biopharmaceutical company focused on the correction of the nonsense mutations that account for 1/3 of all inherited diseases, including approximately 10% of cystic fibrosis. They have combined selected tRNAs with their unique and diverse proprietary delivery platforms to create and develop first-in-class suppressor tRNA-nanoparticle therapeutics for correcting nonsense mutations. ReCode’s diverse pipeline includes lead programs for primary ciliary dy... skinesia (PCD) and nonsense mutations in cystic fibrosis (CF). The company’s proprietary non-viral lipid nanoparticle platform enables the delivery of a variety of payloads, and precise organ targeting of nucleic acid and protein payloads via both systemic and local delivery. ReCode is leveraging its nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated protein replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. The company was founded in 2015 and is based in Dallas, Texas.
RECODE THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Wellness
Founded:
2015-01-01
Address:
Dallas, Texas, United States
Country:
United States
Website Url:
http://www.recodetx.com
Total Employee:
51+
Status:
Active
Contact:
469-306-1618
Email Addresses:
[email protected]
Total Funding:
282 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Universal Analytics Nginx Microsoft Exchange Online Office 365 Mail Nginx 1.14
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Lyra Therapeutics
Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Matrix Capital Management
Matrix Capital Management investment in Series B - ReCode Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Series B - ReCode Therapeutics
Amgen Ventures
Amgen Ventures investment in Series B - ReCode Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - ReCode Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - ReCode Therapeutics
Colt Ventures
Colt Ventures investment in Series B - ReCode Therapeutics
Vida Ventures
Vida Ventures investment in Series B - ReCode Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - ReCode Therapeutics
OrbiMed
OrbiMed investment in Series B - ReCode Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - ReCode Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-25 | ReCode Enlists New CEO to Drive Assets into the Clinic |
| 2022-01-10 | ReCode Therapeutics names its CEO |
| 2021-09-27 | ReCode Therapeutics Appoints Nicholas P. France, M.D., as Senior Vice President of Clinical Development |
Official Site Inspections
http://www.recodetx.com Semrush global rank: 3.74 M Semrush visits lastest month: 3.62 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
